Tags : Extend

Bayer and 111 Collaborate to Explore the Vast Blue Ocean

Shots: The companies will collaborate on drug commercialization initiatives in China, including the commercialization of innovative drugs & healthcare products for chronic disease management, as well as providing reliable and convenient resources for patient education Bayer will leverage 111’s vast network of pharmacies and healthcare providers to enhance its channel management and patient outreach capabilities, […]Read More

Exact Sciences and Pfizer Announce Extension and Amendment of their

Shots: Pfizer will continue to provide sales and marketing support and health system support for Cologuard through the end of 2022 and 2021, respectively. Exact Sciences will compensate Pfizer based on the amount of services provided, along with additional fixed and performance-related fees set forth in the agreement Cologuard was approved by US FDA in […]Read More

Revance and Mylan to Extend Biosimilar to BOTOX Program Decision

Shots: Revance is in discussion with Mylan regarding whether Mylan plans to move forward or not with the biosimilar to BOTOX program. The expected decision date for Mylan is Apr 30, 2020 or thirty days from the date that Revance provides Mylan with certain deliverables regarding the program In Sept’2019, the companies amended their agreement […]Read More